[KROS] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
25-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 11.30%
YoY- -288.08%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 143 0 20,000 0 2,500 -51.07%
PBT -40,243 -29,718 -4,942 -10,676 -2,751 95.47%
Tax 3,812 2 1,998 82 2,302 13.42%
NP -40,243 -29,720 -6,940 -10,676 -2,751 95.47%
Tax Rate - - - - - -
Total Cost 40,386 29,720 26,940 10,676 5,251 66.47%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin -28,141.96 0.00 -34.70 0.00 -110.04 299.52%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -1.34 -1.09 -0.30 -0.49 -0.31 44.15%
EPS Diluted -1.34 -1.09 -0.30 -0.49 -0.31 44.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.